He notes that Oracle is the only company that focuses solely on commercial customers, while other names like Amazon have both commercial ... This post was written by Melanie Riehl Merck & Co. (MRK) ...

Paving The Way For The World’s First Treatment For Cancer Cachexia The mid-stage trial results showed that patients that The FDA approves MRK's Keytruda for first-line treatment of malignant ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other blue chip stocks. While economic data may be scarce, every data point gives a new angle ...

Merck (NYSE:MRK) announced Saturday that its anti-PD-1 therapy Keytruda (pembrolizumab) as part of a combination regimen reduced the risk of death by 20% as a first-line option for certain ...

View Merck & Co., Inc. (MRK) current and estimated P/E ratio data provided by Seeking Alpha.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive top-line results from its pivotal Phase 3 trial (V503-064) evaluating the company’s 9-valent ...

Merck (NYSE: MRK) stock has been a longtime winner for ... The Food and Drug Administration's (FDA's) approval of pembrolizumab, the generic name for Keytruda, in 2014 marked a breakthrough ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Merck (NYSE: MRK), known as MSD outside of the United States ... GARDASIL 9 is commercialized in Japan under the name SILGARD 9. The primary efficacy objective was to demonstrate reduction in ...